The intravenous route is not FDA approved and is generally not recommended except when no other alternatives are available. Intravenous administration appears to be associated with a higher risk of QT prolongation and torsade de pointes (TdP) than other forms of administration. The manufacturer recommends ECG monitoring for QT prolongation and arrhythmias if IV administration is required. A dose in the range of 1 to 5 mg IV has been suggested, with the dose being repeated at 30 to 60 minute intervals, if needed. A maximum IV dose has not been established. The lowest effective dose should be used in conjunction with conversion to oral therapy as soon as possible.
[ back to top ] Other different treatments such as auditory integration training, vitamin and mineral treatments, and secretin injections have been anecdotally reported to be helpful, yet were never proven to make a difference and are not recommended by the American Academy of Neurology; therefore their use is controversial, and not recommended. One must remember that some kids with ASD improve "spontaneously" without any apparent treatment. This makes it difficult to decide whether the improvement was related to a treatment or occurred spontaneously, unless studies are done in a controlled fashion and compared to placebo. Unfortunately, none of the controversial treatments wer ever proven effective in a scientific fashion.
This information should not be used to decide whether or not to take Haldol or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to Haldol. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine.